Sex Differences in the Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta‐Analysis

Documenti analoghi

• Association of Glucagon‐Like Peptide‐1 Receptor Agonist Use With Risk of Psychiatric Disorders: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
  di: Shumeng Han, et al.
  Pubblicazione: (2026)
• Efficacy and Safety of Glucagon‐Like Peptide‐1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta‐Analysis
  di: Abdur Rafay Bilal, et al.
  Pubblicazione: (2026)
• Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?
  di: Zachary Bloomgarden
  Pubblicazione: (2024)
• Positive Islet Cell Cytoplasmic Antibody and Long‐Term Use of Lipid‐Lowering Agents Are Positively Correlated With Peripheral Atherosclerosis in Patients With Autoimmune Diabetes: A Cross‐Sectional Study
  di: Xinyue Chen, et al.
  Pubblicazione: (2025)
• Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
  di: Timothy H. Chan, et al.
  Pubblicazione: (2026)